{"text": "Watchlist for 9/20\n\n$AMD 108c &gt; 107 | 100p &lt; 101.98\n$ABBV 109c &gt; 108.25 | 107p &lt; 107.1\n$AVGO 510c &gt; 507.62 | 500p &lt; 501\n$GOOGL 2770p &lt;2809.4\n$PEP 152.5p &lt; 153.64\n$DPZ 490p &lt; 500.4\n$AMZN 3525c &gt; 3500 | 3400p &lt; 3432\n$SHOP 1550c &gt; 1500, 1400p &lt; 1429\n$TSLA 770c&gt; 765", "created_at": "2021-09-20T06:50:54.000Z", "id": "1439844499199455237", "author_id": "190778335"}
{"created_at": "2021-09-20T23:47:53.000Z", "text": "RT @Dividend_Dollar: \ud83d\udcb0 10 Top Dividend Stocks\n\n\u2615\ufe0f $SBUX\n\ud83d\udeac $MO\n\u2692\ufe0f $HD\n\ud83d\udcb3 $V\n\ud83d\uded2 $WMT\n\ud83d\udcf1 $AAPL\n\ud83c\udfe8 $O\n\ud83d\udc8a $JNJ\n\ud83d\udc89 $ABBV\n\ud83d\udda5\ufe0f $MSFT", "id": "1440100434287398912", "author_id": "1534557739"}
{"text": "$ABBV AbbVie Submits Regulatory Application to FDA for Risankizumab-rzaa (SKYRIZI\u00ae) for the Treatment of Patients 16 Years and Older with Moderate to Severe Crohn's Disease", "author_id": "1262114478986010632", "created_at": "2021-09-20T13:19:34.000Z", "id": "1439942309873864706"}
{"created_at": "2021-09-20T22:08:33.000Z", "text": "RT @wealth_trail: \ufffc\ud83d\udcb010 Dividend Growth Stocks\ufffc\ud83d\udcb0\n\n$V \ufffc\ud83d\udcb3\n$PG \ufffc\ud83e\uddfb\n$HD \ufffc\ud83d\udd28\n$WM \ufffc\u267b\ufe0f\n$NEE \ufffc\u2600\ufe0f\n$LHX \ufffc\ud83d\udce1\n$TXN \u2716\ufe0f\n$UNH \ud83c\udfe5\ufffc\n$ABBV \ufffc\ud83d\udc8a\n$COST \ud83d\uded2", "id": "1440075432926199812", "author_id": "1409442063481987073"}
{"text": "RT @HeroDividend: You can find dividend stocks in many different sectors\ud83d\udcb0\n\nTech\ud83d\udcb0\n$AVGO\n$TXN\n$MSFT\n$INTC\n\nIndustrials\ud83d\udcb0\n$CAT\n$HON\n$LHX\n$MMM\u2026", "author_id": "1272328780850147328", "created_at": "2021-09-20T17:09:51.000Z", "id": "1440000262433755147"}
